FDA approves Alecensa as first adjuvant treatment for people with ALK-positive early-stage lung cancer
Basel- April 2024- Roche announced that the U.S. Food and Drug Administration…
FDA Clears First AI to Aid Heart Failure Detection During Routine Check-Ups
San Francisco- April, 2024- Eko Health, a pioneer in applying artificial intelligence…
Varian Receives FDA 510(k) Clearance for TrueBeam and Edge Radiotherapy Systems
March 2024- Varian, a Siemens Healthineers company, announced that it has received…
Find Why FDA Advisory Committee voted in favor of ABBOTT
ABBOTT PARK, February 2024 - Abbott announced that the Circulatory System Devices…